Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for prevention of postoperative emergence delirium in children undergoing strabismus surgery
PACTR201911530033705Phase 3Recruiting
- Sponsor
- Dr. Mona Raafat El Ghamry
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in Emergence agitation (EA) (2 arms), sponsored by Dr. Mona Raafat El Ghamry. Primary endpoint: Detection of postoperative emergence delirium. Started Nov 2019; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on PACTR201911530033705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201911530033705.